Bank Of New York Mellon Corp Uni Qure N.V. Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $6.04 Million - $9.1 Million	333,156 New	333,156 $7.55 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $923,304 - $1.39 Million	54,376 Added 19.49%	333,334 $6.25 Million
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $5.2 Million - $8.09 Million	-395,607 Reduced 58.65%	278,958 $5.2 Million
Q1 2022 May 11, 2022	SELL	$14.54 - $21.5 $501,281 - $741,234	-34,476 Reduced 4.86%	674,565 $12.2 Million
Q4 2021 Feb 11, 2022	SELL	$20.24 - $36.01 $2.6 Million - $4.63 Million	-128,618 Reduced 15.35%	709,041 $14.7 Million
Q3 2021 Nov 12, 2021	BUY	$26.01 - $38.22 $4.36 Million - $6.4 Million	167,494 Added 24.99%	837,659 $26.8 Million
Q2 2021 Aug 11, 2021	SELL	$29.97 - $37.17 $819,649 - $1.02 Million	-27,349 Reduced 3.92%	670,165 $20.6 Million
Q1 2021 May 13, 2021	BUY	$29.24 - $42.03 $1.32 Million - $1.9 Million	45,265 Added 6.94%	697,514 $23.5 Million
Q4 2020 Feb 09, 2021	BUY	$35.35 - $50.67 $1.52 Million - $2.18 Million	43,012 Added 7.06%	652,249 $23.6 Million
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $2.49 Million - $3.3 Million	69,323 Added 12.84%	609,237 $22.4 Million
Q2 2020 Aug 12, 2020	BUY	$45.06 - $67.74 $2.39 Million - $3.6 Million	53,113 Added 10.91%	539,914 $24.3 Million
Q1 2020 May 06, 2020	SELL	$40.01 - $73.97 $1.22 Million - $2.25 Million	-30,474 Reduced 5.89%	486,801 $23.1 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $3.55 Million - $7.13 Million	95,616 Added 22.68%	517,275 $37.1 Million
Q3 2019 Nov 07, 2019	BUY	$39.36 - $76.8 $13.9 Million - $27.1 Million	352,413 Added 508.93%	421,659 $16.6 Million
Q2 2019 Aug 12, 2019	BUY	$52.76 - $82.19 $1.71 Million - $2.67 Million	32,505 Added 88.47%	69,246 $5.41 Million
Q1 2019 May 14, 2019	BUY	$27.39 - $68.41 $492,855 - $1.23 Million	17,994 Added 95.98%	36,741 $2.19 Million
Q3 2018 Nov 09, 2018	BUY	$29.75 - $43.08 $63,337 - $91,717	2,129 Added 12.81%	18,747 $0
Q2 2018 Aug 06, 2018	BUY	$21.96 - $39.94 $364,931 - $663,722	16,618 New	16,618 $628,000

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account